Appoint pharmacy champions to lead introduction of biosimilars, says NICE NHS trusts should appoint pharmacy and clinical champions to lead on biosimilar medicines, according to the National Institute for Health and Care Excellence.…
Clinical Pharmacist’s monthly news round-up: the top 10 in the past month What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.…
Proposal to involve NICE in approval process for Cancer Drugs Fund The evaluation of drugs currently funded under the Cancer Drugs Fund (CDF) could be passed over to National Institute for Health and Care Excellence (NICE) under proposals drawn up by NHS England.…
New home for prescribing framework All healthcare professionals who prescribe must follow a common set of principles, and the pharmacy profession is an appropriate steward for a prescribing framework.…
NICE’s assessment process is stifling pharmaceutical innovation The way new medicines are assessed should be reformed to provide patients with the best treatments and stimulate research and innovation in the UK.…
Labelling price of medicines won’t solve the real problem Putting the price of a medicine on the packet may not improve medicines adherence and may have unintended consequences, writes Paul Gimson.…
Latest dispensing figures hold no surprisesThe latest report on prescriptions dispensed in the England, from the Health and Social Care Information Centre, make complete sense, writes Chris Chapman.…
Nivolumab granted positive scientific opinion under UK early access scheme Nivolumab, a new lung cancer drug, has been granted a positive scientific opinion by the UK medicines safety regulator under the Early Access to Medicines Scheme (EAMS).…
Repositioning existing drugs for cancer treatment Scientists are using systematic approaches to identify non-oncology drugs that can be used to treat cancer, but access to drugs and commercial challenges are hindering progress.…
NHS England announces ‘huge investment’ for new hepatitis C treatments The NHS in England has agreed to increase the budget available to fund new treatments for chronic hepatitis C to £190m, a rise from the budget of approximately £40m made available in 2014.…